Gund Investment, LLC
VC Fund
Princeton, United States
Gund Investment, LLC is a VC fund in Princeton focused on Medical and Health Care. Private investment firm of Gordon Gund, principal owner of Cleveland Cavaliers National Basketball Association team and member of Board of Governors of National Basketball Association, Cleveland Rockers Womens National Basketball Association franchise, San Jose Sharks National Hockey League team also principal owner and chairman of Nationwide Advertising Service, Inc. and director of Kellogg Company and Corning> Gund also prominent philanthropist, blind since 1970 from retinitis pigmentosa, co-founder with wife and chairman of The Foundation Fighting Blindness, leading private supporter of research focused on discovering causes, treatments, preventions and cures for retinitis pigmentosa, macular degeneration, Usher syndrome, and other retinal degenerative diseases> Investments include Align Technology, Silicon Valley company developed invisible alternative to orthodontic braces.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 29%
Last updated:
For AI agents: llms.txt
Industries Gund Investment, LLC invests in
Stages Gund Investment, LLC invests in
Countries Gund Investment, LLC invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series C
- $10M–$53M
- Venture - Series Unknown
- $5M–$8M
Investment Focus
Industry
- Medical 3 (43%)
- Health Care 3 (43%)
- Biotechnology 2 (29%)
- Medical Device 2 (29%)
- Travel 1 (14%)
Stage
- Venture - Series Unknown 3 (43%)
- Series C 2 (29%)
- Series F 1 (14%)
Country
- United States 4 (57%)
- India 2 (29%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Gordon Gund
President
|
President | Total investments: 0 | Find email | |
|
Warren S. Thaler
President
|
President | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Convergent Dental is a privately-owned dental equipment and technology company developing a computer-aided dental preparation system designed to offer a comfortable patient experience during dental surgeries. It is a carbon-dioxide laser for both hard and soft tissue indications that cuts quietly, finely, and faster than other laser-based systemsin dentistry using patented technologies and computer system controls. | $5M / Venture - Series Unknown / Apr 24, 2023 | ||
| Cleartrip is an online travel platform where travelers can search for and book flights to any destination. They are focused on simplicity, comprehensibility, reliability, and responsibility to give you the best travel service. | Venture - Series Unknown / Jun 21, 2016 | ||
| Bionano Genomics is a biotechnology company that specializes in genome mapping and analysis. The company develops and markets the Saphyr system, which is a platform for ultra-sensitive and ultra-specific structural variation detection in DNA. Structural variations are alterations in the DNA structure, such as insertions, deletions, inversions, andtranslocations, that can be associated with various genetic disorders and diseases, including cancer.Bionano Genomics' Saphyr system uses a technology called optical genome mapping (OGM) to analyze long DNA molecules. OGM allows for the direct visualization and analysis of structural variations in the genome without the need for sequencing. This technology can provide valuable insights into the structural variations in an individual's genome, which can be important for understanding disease mechanisms, and genetic disorders, and for guiding personalized treatment strategies. | $53M / Series C / Nov 20, 2014 | ||
| ZoomIn, India's #1 online photo service, is about connecting people and their moments of magic. | $8M / Venture - Series Unknown / Aug 29, 2014 | ||
| Bionano Genomics is a biotechnology company that specializes in genome mapping and analysis. The company develops and markets the Saphyr system, which is a platform for ultra-sensitive and ultra-specific structural variation detection in DNA. Structural variations are alterations in the DNA structure, such as insertions, deletions, inversions, andtranslocations, that can be associated with various genetic disorders and diseases, including cancer.Bionano Genomics' Saphyr system uses a technology called optical genome mapping (OGM) to analyze long DNA molecules. OGM allows for the direct visualization and analysis of structural variations in the genome without the need for sequencing. This technology can provide valuable insights into the structural variations in an individual's genome, which can be important for understanding disease mechanisms, and genetic disorders, and for guiding personalized treatment strategies. | $10M / Series C / Oct 02, 2013 | ||
| Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, one of the world’s leading causes of blindness. They have pioneered Micro-Invasive Glaucoma Surgery, or MIGS, in order to revolutionize thetraditional glaucoma treatment and management paradigm.They launched the iStent®, their first MIGS device, in the United States in 2012. They are leveraging their platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. They believe the iStent® is the smallest medical device ever approved by the Food and Drug Administration, or FDA, measuring 1.0 mm long and 0.33 mm wide.In June 2015, they completed an initial public offering and their shares are now traded on the New York Stock Exchange under the ticker symbol “GKOS”. The company was founded in 1998 and is based in San Clemente, California. | $30M / Series F / Feb 05, 2013 | ||
| Ophthonix, Inc. manufactures and markets high resolution spectacle lenses for vision assessment and correction applications. It offers its high resolution lenses for single vision spectacle lenses for the correction of myopia, hyperopia, and mild astigmatism; and progressive addition spectacle lenses. The company sells its products throughpractitioners in the United States and European countries. Ophthonix, Inc. was founded in 2000 and is based in Vista, California. | $17M / Series C / Oct 11, 2005 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Gund Investment, LLC invest in?
Gund Investment, LLC invests primarily in Medical, Health Care and Biotechnology startups, most often at Venture - Series Unknown and Series C stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Gund Investment, LLC invest in?
Gund Investment, LLC typically joins rounds of $10M–$53M at Series C and $5M–$8M at Venture - Series Unknown. These are whole funding-round sizes, not Gund Investment, LLC's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Gund Investment, LLC took part in.
How do I contact Gund Investment, LLC?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Gund Investment, LLC?
The team at Gund Investment, LLC includes Gordon Gund (President) and Warren S. Thaler (President). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
